Affiliation:
1. Tomsk Regional Oncology Dispensary
2. Tomsk Regional Oncology Dispensary; Tomsk National Research Polytechnic University
3. Russian State Research Center — Burnazyan Federal Medical Biophysical Centre; Moscow Pedagogical State University
Abstract
Cervical cancer is a socially significant illness often impacting women of reproductive and working age. The patients’ young age and social activity warrant the development of effective and safe therapies.The past decades have witnessed the novel radiation techniques to contain cervical cancer: 3DCRT-3D, IMRT, and VMAT, adaptive radiotherapy, CT/MRI-guided intracavitary radiation, combined interstitial and intracavitary radiation, abandoning intracavitary intervention for external beam delivery with sequential or concurrent cervical dose escalation, under brachytherapy unfeasible.Modern equipment and treatment planning systems allow a high dose delivery to the tumour and intracavitary treatment with visual control of the target and organs at risk. Combining of intracavitary and interstitial radiotherapy enables a better dose coverage of the target at a minimal radiation impact on organs at risk.Phasing-out of intracavitary for external radiotherapy may enable a cancericide dose delivery to the tumour under intractable intracavitary treatment.The major goal of technic novelties is the establishment of personalised radiotherapy for improving treatment outcomes and reducing the incidence and/or severity of radiation side effects. The article overviews the radiotherapy techniques for cervical cancer treatment and routes of their development.
Publisher
Bashkir State Medical University
Subject
General Engineering,Energy Engineering and Power Technology
Reference39 articles.
1. Kravets O.A., Kuznetsov V.V., Morkhov K.Yu., Nechushkina V.M., Khokhlova S.V. Cervical cancer: clinical practice guideline. Moscow; 2018 (In Russ.).
2. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, Feb 4. DOI: 10.3322/caac.21660
3. Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin Kh., et al. HPV-associated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019;21(1):45–50 (In Russ.). DOI: 10.26442/18151434.2019.190199
4. Arkhangelskaya P.A., Bakhidze E.V., Berlev I.V., Samsonov R.B., Ivanov M.K., Malek A.V. MicroRNA, HPV and cervical carcinogenesis: molecular aspects and prospects of clinical application. Siberian journal of oncology. 2016;15(4):88–97 (In Russ.). DOI:10.21294/1814-4861-2016-15-4-88-97
5. Kravets O.A., Romanova E.A., Gorbunova V.A. Clinical results of radiation and chemoradiation therapy of locally advanced cervix cancer. Russian Journal of Oncology. 2020;25(3):92–102 (In Russ.). DOI: 10.17816/1028-9984-2020-25-3-92-102
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献